Angiogenesis and arteriogenesis: The long journey from concept to clinical application;Angiogenese en arteriogenese; de lange weg van concept naar klinische toepassing

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 14, 2001, Pages 670-675

  Voskuil, M ^a   Van Royen, N ^a   Hoefer, I ^a   Buschmann, I ^a   Schaper, W ^a   Piek, J J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL PROLIFERATION; COMPARATIVE STUDY; ENDOTHELIUM CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TISSUE BLOOD FLOW;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOLES; CAPILLARIES; CHEMOKINE CCL2; COLLATERAL CIRCULATION; ENDOTHELIAL GROWTH FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035820323     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. New trends in the interventional treatment of ischaemic heart disease
2. Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization
3. The role of triple therapy in patients with chronic stable angina pectoris
4. The collateral circulation of the limb
5. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
6. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial
7. Mechanisms of angiogenesis
8. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
9. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border
10. Therapeutische angiogenese door intramusculaire toediening van het gen voor vasculaire endotheliale groeifactor (VEGF)
11. Therapeutische angiogenese als nieuwe experimentele behandeling voor vaatpatiënten
12. Collateral circulation and diabetes
13. Molecular mechanisms of coronary collateral vessel growth
14. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium
15. Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells
16. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells
17. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
18. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
19. Human monocyte chemoattractant protein-1 (MCP-1)
20. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase
21. Monocyte chemotactic protein- 1 increases collateral and peripheral conductance after femoral artery occlusion
22. Role of colony stimulating factors during arteriogenesis (growth of collateral arteries)
23. Anti-adhesion monoclonal antibodies against ICAM inhibit arteriogenesis
24. GM-CSF promotes collateral artery growth via prolongation of macrophage survival
25. Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation
26. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion
27. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits
28. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
29. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
30. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
31. Double blind, placebo controlled trial of recombinant human vascular growth factor - The VIVA trial
32. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
33. Comparison of collateral vascular responses in the donor and recipient coronary artery during transient coronary occlusion assessed by intracoronary blood flow velocity analysis in patients
34. Quantification of collateral flow in humans: A comparison of angiographic, electrocardiographic and hemodynamic variables
35. Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease
36. Angiogenesis in ischemic heart disease
37. bFGF increases collateral blood flow in aged rats with femoral artery ligation
38. Heparin and angiogenic therapy
39. Mechanisms of angiogenesis and arteriogenesis